StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Zomedica's free cash flow for the twelve months ending Jun 30, 2026 was -$13.67M. For fiscal 2025 it was -$18.22M. The highest annual figure on record is -$4.79M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.22M–
FY2024Dec 31, 2024-$28.84M–
FY2023Dec 31, 2023-$27.31M–
FY2022Dec 31, 2022-$12.46M–
FY2021Dec 31, 2021-$14.42M–
FY2020Dec 31, 2020-$16.25M–
FY2019Dec 31, 2019-$15.79M–
FY2018Dec 31, 2018-$11.78M–
FY2017Dec 31, 2017-$7.26M–
FY2016Dec 31, 2016-$4.79M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.64M–
Q1 FY2026Mar 31, 2026-$5.32M–
Q4 FY2025Dec 31, 2025-$1.01M–
Q3 FY2025Sep 30, 2025-$4.70M–
Q2 FY2025Jun 30, 2025-$5.58M–
Q1 FY2025Mar 31, 2025-$6.93M–
Q4 FY2024Dec 31, 2024-$5.10M–
Q3 FY2024Sep 30, 2024-$5.87M–
Q2 FY2024Jun 30, 2024-$7.94M–
Q1 FY2024Mar 31, 2024-$9.93M–
Q4 FY2023Dec 31, 2023-$7.05M–
Q3 FY2023Sep 30, 2023-$9.50M–
Q2 FY2023Jun 30, 2023-$5.54M–
Q1 FY2023Mar 31, 2023-$5.23M–
Q4 FY2022Dec 31, 2022-$2.59M–
Q3 FY2022Sep 30, 2022-$3.20M–
Q2 FY2022Jun 30, 2022-$4.11M–
Q1 FY2022Mar 31, 2022-$2.55M–
Q4 FY2021Dec 31, 2021-$4.95M–
Q3 FY2021Sep 30, 2021-$5.05M–
Q2 FY2021Jun 30, 2021-$1.77M–
Q1 FY2021Mar 31, 2021-$2.65M–
Q4 FY2020Dec 31, 2020-$2.70M–
Q3 FY2020Sep 30, 2020-$5.66M–
Q4 FY2019Dec 31, 2019-$1.87M–
Q3 FY2019Sep 30, 2019-$3.99M–
Q2 FY2019Jun 30, 2019-$8.44M–
Q1 FY2019Mar 31, 2019-$2.65M–
Q4 FY2018Dec 31, 2018-$3.35M–
Q3 FY2018Sep 30, 2018-$3.84M–
Q2 FY2018Jun 30, 2018-$2.86M–
Q1 FY2018Mar 31, 2018-$1.72M–
Q4 FY2017Dec 31, 2017-$1.99M–
Q3 FY2017Sep 30, 2017-$1.45M–
Q2 FY2017Jun 30, 2017-$2.11M–
Q1 FY2017Mar 31, 2017-$1.71M–

More Zomedica figures

See a number that looks wrong?